Validation of a Microsampling-Compatible LC-MS/MS Method for Cannabinoid Quantitation in Whole Blood
Aman A MohammediD, Mahmood Khan, Herbert Chan, Jeffrey R Brubacher
Abstract
Recently developed dried blood sampling methods for cannabinoid quantitation require small blood volumes, making them microsampling-compatible, but have notable limitations including hematocrit-related bias for dried blood spots (DBS) and higher consumable costs for volumetric absorptive microsampling (VAMS(R)). To address these issues, we developed a highly sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method capable of quantifying cannabinoids in 50 {micro}L of liquid whole blood, providing a practical microsampling alternative to dried blood approaches. Using liquid-liquid extraction (LLE) with sodium hydroxide alkalinization and acetonitrile precipitation, followed by quantitative analysis on an Agilent 6495 liquid chromatography-triple quadrupole (LC-TQ) mass spectrometer, we achieved lower limits of quantitation (LLOQs) of 0.10 ng/mL for {Delta}9-tetrahydrocannabinol (THC) and cannabinol (CBN), 0.20 ng/mL for cannabigerol (CBG), 0.30 ng/mL for cannabidiol (CBD), 0.50 ng/mL for 11-hydroxy-THC (11-OH-THC), and 5.0 ng/mL for 11-nor-9-carboxy-THC (THC-COOH). Calibration was linear from the LLOQ to 300 ng/mL for all analytes. To our knowledge, this is the first validated approach for cannabinoid quantitation in less than 100 {micro}L of liquid whole blood with an LLOQ for THC comparable to that with the most sensitive LC-MS/MS methods using standard blood volumes. The achieved LLOQs for other cannabinoids are also suitable for forensic toxicology applications. We anticipate particular utility for obtaining evidence from suspected impaired drivers at the roadside when paired with finger-prick sampling and liquid blood microcollection tubes.This approach enables measurement of THC levels at the time of driving and thereby overcoming current limitations, including the decrease in THC levels that occurs if blood sampling is delayed, the requirement for larger sample volumes ([≥]100 {micro}L), and dependence on trained phlebotomists for venipuncture.
02 /Specification & Classification
Click any tag to browse matching papers- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Quantifying 64 drugs, illicit substances, and D- and L- isomers in human oral fluid with liquid-liquid extraction
B. Robbins, R. E. Carpenter, … J. Perry·bioRxiv·Oct 29, 2022
- Non-targeted Screening of Commercial CBD Products in the United States Reveals Common Contamination and Adulteration
B. Orsburn·bioRxiv·Aug 25, 2020
- Analysis of D- and L- Isomers of (Meth)amphetamine in Human K2EDTA Plasma
B. Robbins, J. Perry, … R. E. Carpenter·bioRxiv·Nov 20, 2022
- Pharmacokinetics and Central Accumulation of Delta-9-Tetrahydrocannabinol (THC) and its Bioactive Metabolites are Influenced by Route of Administration and Sex
Samantha L. Baglot, Catherine Hume, … Matthew N. Hill·Scientific ReportsPeer-reviewed·Dec 14, 2021
- A field method to optimize dried blood spot sampling for mercury biomonitoring
Christopher J. Sayers, Liz Huamani Valdivia, … Morgan W. Tingley·Environmental PollutionPeer-reviewed·Oct 1, 2026
- Cannabidiol Toxicity Driven by Hydroxyquinone Formation
Metzli I. Montero, Pravien S. Rajaram, … Roberto C. Andresen Eguiluz·Chemical Research in ToxicologyPeer-reviewed·Jan 29, 2025